The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Efficient Intracellular Assembly of Papillomaviral Vectors
Open accessAbstract
Although the papillomavirus structural proteins, L1 and L2, can spontaneously coassemble to form virus-like particles, currently available methods for production of L1/L2 particles capable of transducing reporter plasmids into mammalian cells are technically demanding and relatively low-yield. In this report, we describe a simple 293 cell transfection method for efficient intracellular production of papillomaviral-based gene transfer vectors carrying reporter plasmids. Using bovine papillomavirus type 1 (BPV1) and human papillomavirus type 16 as model papillomaviruses, we have developed a system for producing papillomaviral vector stocks with titers of several billion transducing units per milliliter. Production of these vectors requires both L1 and L2, and transduction can be prevented by papillomavirus-neutralizing antibodies. The stocks can be purified by an iodixanol (OptiPrep) gradient centrifugation procedure that is substantially more effective than standard cesium chloride gradient purification. Although earlier data had suggested a potential role for the viral early protein E2, we found that E2 protein expression did not enhance the intracellular production of BPV1 vectors. It was also possible to encapsidate reporter plasmids devoid of BPV1 DNA sequences. BPV1 vector production efficiency was significantly influenced by the size of the target plasmid being packaged. Use of 6-kb target plasmids resulted in BPV1 vector yields that were higher than those with target plasmids closer to the native 7.9-kb size of papillomavirus genomes. The results suggest that the intracellular assembly of papillomavirus structural proteins around heterologous reporter plasmids is surprisingly promiscuous and may be driven primarily by a size discrimination mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
Kirnbauer, R., Taub, J. W., Greenstone, H. L., Roden, R. B. S., Dürst, M., Gissmann, L., Lowy, D. R., & Schiller, J. T. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.6929-6936.1993 · Cited by 608
Self-citationAnimal models of papillomavirus pathogenesis
Campo, M. S. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00193-4 · Cited by 277
Roden, R. B., Greenstone, H. L., Kirnbauer, R., Booy, F. P., Jessie, J., Lowy, D. R., & Schiller, J. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5875-5883.1996 · Cited by 275
Self-citationHuman papillomavirus life cycle: active and latent phases
Stubenrauch, F., & Laimins, L. A. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0141 · Cited by 273
Christensen, N. D., Dillner, J., Eklund, C., Carter, J. J., Wipf, G. C., Reed, C. A., Cladel, N. M., & Galloway, D. A. (1996) · Virology · doi:10.1006/viro.1996.0466 · Cited by 255
Zhou, J., Liu, W. J., Peng, S. W., Sun, X. Y., & Frazer, I. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4972-4982.1999 · Cited by 253
Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells
Lenz, P., Day, P. M., Pang, Y.-Y. S., Frye, S. A., Jensen, P. N., Lowy, D. R., & Schiller, J. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5346 · Cited by 252
Self-citationDay, P. M., Roden, R. B. S., Lowy, D. R., & Schiller, J. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.142-150.1998 · Cited by 205
Self-citation
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Molecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Schowalter, R. M., Pastrana, D. V., Pumphrey, K. A., Moyer, A. L., & Buck, C. B. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.006 · Cited by 594
Self-citationRoberts, J. N., Buck, C. B., Thompson, C. D., Kines, R., Bernardo, M., Choyke, P. L., Lowy, D. R., & Schiller, J. T. (2007) · Nature Medicine · doi:10.1038/nm1598 · Cited by 503
Self-citationCarrageenan is a potent inhibitor of papillomavirus infection
Buck, C. B., Thompson, C. D., Roberts, J. N., Müller, M., Lowy, D. R., & Schiller, J. T. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020069 · Cited by 497
Self-citationRichards, R. M., Lowy, D. R., Schiller, J. T., & Day, P. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508815103 · Cited by 375
Self-citationDurfee, L. A., Lyon, N., Seo, K., & Huibregtse, J. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.002 · Cited by 358
Pastrana, D. V., Buck, C. B., Pang, Y.-Y. S., Thompson, C. D., Castle, P. E., FitzGerald, P. C., Krüger Kjaer, S., Lowy, D. R., & Schiller, J. T. (2004) · Virology · doi:10.1016/j.virol.2003.12.027 · Cited by 357
Self-citationArrangement of L2 within the Papillomavirus Capsid
Buck, C. B., Cheng, N., Thompson, C. D., Lowy, D. R., Steven, A. C., Schiller, J. T., & Trus, B. L. (2008) · Journal of Virology · doi:10.1128/jvi.02726-07 · Cited by 349
Self-citationEstablishment of human papillomavirus infection requires cell cycle progression
Pyeon, D., Pearce, S. M., Lank, S. M., Ahlquist, P., & Lambert, P. F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000318 · Cited by 348
“means for producing high yields of infectious virus have only recently been attained [10,11].”
BackgroundMethodTolstov, Y. L., Pastrana, D. V., Feng, H., Becker, J. C., Jenkins, F. J., Moschos, S., Chang, Y., Buck, C. B., & Moore, P. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24509 · Cited by 339
Self-citationCurrent understanding of the mechanism of HPV infection
Schiller, J. T., Day, P. M., & Kines, R. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.04.004 · Cited by 332
Self-citationVirus-like particles: flexible platforms for vaccine development
Chackerian, B. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.381 · Cited by 321
Generation of HPV Pseudovirions Using Transfection and Their Use in Neutralization Assays
Buck, C. B., Pastrana, D. V., Lowy, D. R., & Schiller, J. T. (2005) · Human Papillomaviruses · doi:10.1385/1-59259-982-6:445 · Cited by 298
Self-citationUnderstanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 293
Self-citationMaturation of Papillomavirus Capsids
Buck, C. B., Thompson, C. D., Pang, Y.-Y. S., Lowy, D. R., & Schiller, J. T. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2839-2846.2005 · Cited by 289
Self-citationL2, the minor capsid protein of papillomavirus
Wang, J. W., & Roden, R. B. S. (2013) · Virology · doi:10.1016/j.virol.2013.04.017 · Cited by 266
Human papillomavirus molecular biology
Harden, M. E., & Munger, K. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.002 · Cited by 260
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Pastrana, D. V., Tolstov, Y. L., Becker, J. C., Moore, P. S., Chang, Y., & Buck, C. B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000578 · Cited by 254
Self-citationMucin biopolymers as broad-spectrum antiviral agents
Lieleg, O., Lieleg, C., Bloom, J., Buck, C. B., & Ribbeck, K. (2012) · Biomacromolecules · doi:10.1021/bm3001292 · Cited by 167
Self-citationLi, J., Wang, X., Diaz, J., Tsang, S. H., Buck, C. B., & You, J. (2013) · Journal of Virology · doi:10.1128/jvi.01216-13 · Cited by 128
Self-citationCruising the cellular highways: how human papillomavirus travels from the surface to the nucleus
DiGiuseppe, S., Bienkowska-Haba, M., Guion, L. G., & Sapp, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.10.015 · Cited by 67
Metadata
- Authors
- Buck, C. B., Pastrana, D. V., Lowy, D. R., & Schiller, J. T.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2004-01-15
- Volume
- 78
- Issue
- 2
- Pages
- 751-757
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2106682089
- Cited by
- 489
- References
- 37
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.